Page 135 - ITPS-7-2

INNOSC Theranostics and
Pharmacological Sciences PI3K-α inhibitors for cancer immunotherapy

ligand complex crystals. Acta Crystallogr D Struct Biol. activities of new sulfonamides 4-substituted-triazolyl
2017;73:79-92. nucleosides. Bioorg Med Chem Lett. 2017;27(9):1989-1992.
doi: 10.1107/S2059798316020271 doi: 10.1016/j.bmcl.2017.03.018
53. Guterres H, Park SJ, Jiang W, Im W. Ligand-binding-site 64. Stokes SS, Albert R, Buurman ET, et al. Inhibitors of the
refinement to generate reliable holo protein structure acetyltransferase domain of N-acetylglucosamine-1-
conformations from apo structures. J Chem Inf Model. phosphate-uridylyltransferase/glucosamine-1-phosphate-
2020;61(1):535-546. acetyltransferase (GlmU). Part 2: Optimization of physical
doi: 10.1021/acs.jcim.0c01354 properties leading to antibacterial aryl sulfonamides. Bioorg
Med Chem Lett. 2012;22(23):7019-7023.
54. Shin WH, Kumazawa K, Imai K, Hirokawa T, Kihara D.
Current challenges and opportunities in designing protein- doi: 10.1016/j.bmcl.2012.10.003
protein interaction targeted drugs. Adv Appl Bioinform 65. Konda S, Raparthi S, Bhaskar K, et al. Synthesis and
Chem. 2020;13:11-25. antimicrobial activity of novel benzoxazine sulfonamide
doi: 10.2147/AABC.S235542 derivatives. Bioorg Med Chem Lett. 2015;25(7):1643-1646.
55. Halgren TA. Identifying and characterizing binding sites and doi: 10.1016/j.bmcl.2015.01.026
assessing druggability. J Chem Inf Model. 2009;49(2):377-389. 66. Durgun M, Turkmen H, Zengin G, Zengin H, Koyunsever M,
doi: 10.1021/ci800324m Koyuncu I. Synthesis, characterization, in vitro cytotoxicity and
antimicrobial investigation and evaluation of physicochemical
56. De Wolf FA, Brett GM. Ligand-binding proteins: Their properties of novel 4-(2-methylacetamide)benzenesulfonamide
potential for application in systems for controlled delivery derivatives. Bioorg Chem. 2017;70:163-172.
and uptake of ligands. Pharmacol Rev. 2000;52(2):207-236.
doi: 10.1016/j.bioorg.2016.12.007
57. Sriramulu DK, Lee SG. Combinatorial effect of ligand and
ligand-binding site hydrophobicities on binding affinity. 67. Lal J, Gupta SK, Thavaselvam D, Agarwal DD. Biological
J Chem Inf Model. 2020;60(3):1678-1684. activity, design, synthesis and structure activity relationship
of some novel derivatives of curcumin containing
doi: 10.1021/acs.jcim.9b01143 sulfonamides. Eur J Med Chem. 2013;64:579-588.
58. Shin YS, Lee JY, Noh S, et al. Discovery of cyclic sulfonamide doi: 10.1016/j.ejmech.2013.03.012
derivatives as potent inhibitors of SARS-CoV-2. Bioorg Med
Chem Lett. 2021;31:127667. 68. Ning X, Guo Y, Ma X, et al. Design, synthesis and
pharmacological evaluation of (E)-3,4-dihydroxy styryl
doi: 10.1016/j.bmcl.2020.127667 sulfonamides derivatives as multifunctional neuroprotective
59. Wan Y, Fang G, Chen H, Deng X, Tang Z. Sulfonamide agents against oxidative and inflammatory injury. Bioorg
derivatives as potential anti-cancer agents and their SARs Med Chem. 2013;21(17):5589-5597.
elucidation. Eur J Med Chem. 2021;226:113837. doi: 10.1016/j.bmc.2013.05.043
doi: 10.1016/j.ejmech.2021.113837 69. Abbas A, Murtaza S, Tahir MN, et al. Synthesis, antioxidant,
60. Hamed FM, Hassan BA, Abdulridha MM. The antitumor enzyme inhibition and DNA binding studies of novel
activity of sulfonamides derivatives: Review. Int J Pharm Res. N-benzylated derivatives of sulfonamide. J Mol Struct.
2020;12:2512. 2016;1117:269-275.
doi: 10.31838/ijpr/2020.SP1.390 doi: 10.1016/j.molstruc.2016.03.066
61. Ghorab MM, Alsaid MS, El-Gaby MSA, Safwat NA, Elaasser 70. Chandna N, Kumar S, Kaushik P, et al. Synthesis of
MM, Soliman AM. Biological evaluation of some new N-(2,6- novel celecoxib analogues by bioisosteric replacement
dimethoxypyrimidinyl) thioureido benzenesulfonamide of sulfonamide as potent anti-inflammatory agents
derivatives as potential antimicrobial and anticancer agents. and cyclooxygenase inhibitors. Bioorg Med Chem.
Eur J Med Chem. 2016;124:299-310. 2013;21(15):4581-4590.
doi: 10.1016/j.ejmech.2016.08.060 doi: 10.1016/j.bmc.2013.05.029
62. Bano S, Javed K, Ahmad S, Rathish IG, Singh S, Alam 71. Lu XY, Wang ZC, Ren SZ, Shen FQ, Man RJ, Zhu HL.
MS. Synthesis and biological evaluation of some new Coumarin sulfonamides derivatives as potent and selective
2-pyrazolines bearing benzene sulfonamide moiety as COX-2 inhibitors with efficacy in suppressing cancer
potential anti-inflammatory and anti-cancer agents. Eur J proliferation and metastasis. Bioorg Med Chem Lett.
Med Chem. 2011;46(12):5763-5768. 2016;26(15):3491-3498.
doi: 10.1016/j.ejmech.2011.08.015 doi: 10.1016/j.bmcl.2016.06.037
63. Alaoui S, Dufies M, Driowya M, et al. Synthesis and anti-cancer 72. Naim MJ, Alam O, Alam MJ, et al. Design, synthesis and

Volume 7 Issue 2 (2024) 25 doi: 10.36922/itps.2340